AN2 Therapeutics (ANTX) has had the highest return since January 1, 2026 by a US stock with an IPO date in 2022, returning 411.6%.
| ASSET | % RETURN |
|---|---|
AN2 Therapeutics (ANTX) | 411.61% |
Swvl (SWVL) | 279.68% |
Nuvectis Pharma (NVCT) | 196.61% |
Zhong Yang Financial Group Limited Ordinary Shares (TOP) | 189.31% |
Definium Therapeutics (DFTX) | 181.41% |
Amylyx Pharmaceuticals (AMLX) | 170% |
Himalaya Shipping (HSHP) | 118.1% |
OmniAb (OABI) | 117.03% |
United Maritime (USEA) | 86.99% |
Westrock Coffee (WEST) | 85.1% |
JE Cleantech (JCSE) | 83.12% |
Permian Resources (PR) | 71.34% |
John Wiley & Sons (WLY) | 58.75% |
John Wiley & Sons B (WLYB) | 57.85% |
RXO (RXO) | 57.8% |
EON Resources (EONR) | 55% |
Prenetics Global (PRE) | 51.88% |
M-tron Industries (MPTI) | 47.45% |
Excelerate Energy (EE) | 42.21% |
ProFrac (ACDC) | 40.15% |
FGI Industries (FGI) | 37.79% |
Heart Test Laboratories Inc Common Stock (HSCS) | 32.04% |
GigaCloud Technology Inc Class A Ordinary Shares (GCT) | 32.01% |
Biohaven (BHVN) | 31.93% |
SeaStar Medical (ICU) | 31.36% |